Register Now

2013 Speakers

top ^

David B. Agus, MD

Professor of Medicine & Engineering, University of Southern California; Author, A Short Guide to a Long Life

David Agus is one of the world’s top cancer doctors and a pioneer in new technologies for personalized health care. A professor at USC, with appointments in both the Keck School of Medicine and the Viterbi School of Engineering, he also heads the university’s Westside Cancer Center and the Center for Applied Molecular Medicine. He has cofounded several businesses, including the genetic testing company Navigenics and He is also a cofounder of Applied Proteomics, which aims to tap the tremendous wealth of information contained in the body’s proteome—the complete set of all proteins circulating in the bloodstream—for earlier diagnosis of disease. Agus is a CBS News contributor and author of the number one New York Times best seller The End of Illness. His new book, A Short Guide to a Long Life, will be published in January 2014.

top ^

Partner Presentation

Ronald DePinho, MD

President, The University of Texas MD Anderson Cancer Center

Ronald DePinho is one of the world’s preeminent researchers on the molecular underpinnings of cancer and aging, and the translation of that knowledge into clinical advances. He was appointed president of the MD Anderson Cancer Center in Houston in 2011. Before that, he was a professor of medicine and genetics at Harvard Medical School for fourteen years and founding director of the Belfer Institute for Applied Cancer Science at the Dana-Farber Institute in Boston. He also co-chaired the advisory boards for the NCI Mouse Models of Human Cancers Consortium and the Cancer Genome Atlas Project. DePinho’s discoveries have been honored with a long list of awards—not to mention an appearance on The Colbert Report in January 2011, after his Harvard lab successfully reversed age degeneration in mice—and he was recently elected to both the National Academy of Sciences and the American Academy of Arts and Sciences.

top ^

Sponsor Presentation

Courtney DiNardo, MD

Assistant Professor, The University of Texas MD Anderson Cancer Center

Courtney DiNardo is a nationally recognized clinical oncologist and faculty member in the Department of Leukemia at MD Anderson Cancer Center. A specialist in epidemiology and biostatistics, she is researching the use of genetic and epigenetic profiling to help doctors develop personalized treatment plans and improve risk assessments. DiNardo has played a key role in training IBM’s Watson computer to serve as an expert advisor in leukemia care, tracking a patient’s condition and identifying connections between their individual case and the full body of medical knowledge. She is also engaged in a number of ongoing clinical trials, helps draft protocols for leukemia treatment, and serves as an ad hoc reviewer for several respected medical journals. 

top ^

Sean Duffy

Cofounder & CEO, Omada Health

Omada Health has launched an online program to help patients at risk for diabetes make healthy lifestyle changes, using web-based lessons, coaching, social support, and digital tracking tools. Sean Duffy dropped out of an MD/MBA program at Harvard to cofound Omada. He previously spent two years at Google and worked in IDEO’s Health & Wellness group.

top ^

Rushika Fernandopulle, MD

CEO, Iora Health

Rushika Fernandopulle cofounded Iora Health with the goal of reinventing patient care from the ground up. The company, based in Cambridge, Massachusetts, is developing a new practice model for physicians, one they hope will provide better outcomes and greater patient satisfaction while lowering overall health care costs. The goal is to encourage, rather than discourage, engagement with primary-care providers, including regular communications via email, text, and video chat. Iora Health has opened four test practices so far, with more planned. Fernandopulle is on the faculty of Harvard Medical School, where he was the first executive director of the Harvard Interfaculty Program for Health Systems Improvement; he also serves on the staff at Massachusetts General Hospital. He is the coauthor of Health Care Policy, a textbook for physicians and medical students, and Uninsured in America: Life and Death in the Land of Opportunity.

top ^

Elizabeth Holmes

Founder & CEO, Theranos

Elizabeth Holmes founded Theranos in 2003. After ten years of development of novel analytical solutions, the company is now introducing its breakthrough laboratory services to people and their physicians as part of routine clinical care. Requiring just a few drops of blood that can be taken from a finger stick—no more large needles or vials—the Theranos infrastructure provides a full range of lab tests with fast and accurate results at a fraction of the cost. Holmes describes Theranos as a consumer-oriented health-tech company; her goal is to expand patients’ access to actionable information, making possible earlier disease detection and intervention. In September, Theranos announced the launch of its sample-collection centers, known as Theranos Wellness Centers, which will be rolled out nationwide.

top ^

Mike Huang

Cofounder & CEO, Glow

Mike Huang is CEO of Glow, a new startup that’s tapping the power of machine learning to solve a very intimate problem—helping couples get pregnant. The company’s mobile app, which launched in August of this year, predicts a woman’s daily fertility level based on personal information she enters, then pools the data collected anonymously from the entire user base to improve its algorithm. There’s also an innovative option called Glow First, which offers financial assistance on fertility treatments for those who fail to conceive naturally after ten months. Glow is the second commercial application of big-data analytics spun off by HVF, an R&D/investment firm started by PayPal cofounder Max Levchin. Before cofounding Glow, Huang was executive vice president of Slide Asia, where he built and ran the company’s first international division in China. When Slidewas acquired by Google in 2010, Huang joined Google as director of product management.

top ^

Andrea Hudy

Assistant Athletic Director of Sports Performance,
University of Kansas

Andrea Hudy is the strength and conditioning coach for the University of Kansas men’s basketball team. Since she joined the storied Division I team in 2004, the Jayhawks have won six Big 12 Conference championships; in 2008 they won the NCAA national championship. She has implemented a cutting-edge training program at Kansas, using advanced technologies to optimize workouts for each athlete and analyze their performance—for instance, with computer vision systems that measure instantaneous power and velocity, crucial metrics that were previously impossible to quantify. Before joining Kansas, Hudy spent a decade at the University of Connecticut, where she trained eight national championship teams, including five in women’s basketball. In January 2013, she was named the National College Strength and Conditioning Coach of the Year.

top ^

David Icke


Dave Icke is CEO of MC10, a Cambridge, Massachusetts, startup that aims to redefine the interface between electronics and the human body. Using a breakthrough stretchable circuit technology, the company is developing a new generation of ultrathin, flexible devices that can be worn on the skin or implanted internally, opening new possibilities in health monitoring, diagnostics, and therapeutic delivery. Icke began his career as a process engineer at Cypress Semiconductor and spent 11 years at KLA-Tencor. He later led several businesses at Teradyne and served in a variety of executive roles at Advanced Electron Beams before joining MC10 in 2009. Under his leadership, the company has made rapid strides in commercializing its new technology and attracting major industry partners. MC10 won the Wall Street Journal’s Technology Innovation Award last year and was honored as a 2013 Technology Pioneer by the World Economic Forum.

top ^

Elli Kaplan

Cofounder & CEO, Neurotrack

Neurotrack is developing a cognitive test that can detect the first neurological effects of Alzheimer’s, up to six years before the onset of behavioral symptoms. Early diagnosis is a great advantage for patients, giving them time to plan and take steps that can delay the onset of the disease. Before cofounding Neurotrack, Elli Kaplan worked in the public sector and held senior positions with AIG Capital Partners and Goldman Sachs, as well as several startups.

top ^

Martin Krzywinski

Staff Scientist, Canada's Michael Smith Genome Sciences Center

Martin Krzywinski is renowned for his pioneering work in bioinformatics and data visualization. In 2005 he created a software tool called Circos to display massive genomic data sets in a way that both revealed their inner structure and was visually stunning. The distinctive circular graph has since been adopted in many fields, appearing in numerous magazines and journals, including cover images for both Science and Nature. More recently, he introduced a new graphic known as a hive plot for visualizing network relationships. Krzywinski’s work has not only set a new standard for the visual presentation of scientific results, it has established design as an integral tool in the research process itself. He believes that scientists have a duty to communicate clearly and connect emotionally with their audience, sparking imagination and enthusiasm for the pursuit of understanding. 

top ^

David H. Newman, MD

Director of Clinical Research, Emergency Medicine, Mt. Sinai;
Editor in Chief,

David H. Newman is a practicing physician at Mt. Sinai, where he also teaches and serves as director of clinical research in the department of emergency medicine. He has emerged as a leading voice for change in our health care system, and a critic of reform efforts that focus on cost reduction. The real problem, he argues in his book Hippocrates’ Shadow: Secrets from the House of Medicine, is a dysfunctional medical culture whose goals and interests are often at odds with those of patients. An advocate for evidence-based medicine, Newman co-created, a website that summarizes research data on the effectiveness of therapies and diagnostics in a way that is broadly accessible and understandable. As a major in the Army Reserves in 2005, Newman served with a combat support hospital in Baghdad, for which he received an Army Commendation Medal.

top ^

Hugh Rienhoff, MD

Geneticist & Entrepreneur; Founder,

After training as a clinical scientist in the 1980s, Hugh Rienhoff joined the venture capital firm New Enterprise Associates, where he directed biotech investments. In 1998 he founded DNA Sciences, serving as chairman and CEO for four years. He was also a founding director of Healtheon/WebMD and Aurora Biosciences. His latest startup, FerroKin BioSciences, was acquired by Shire Pharmaceuticals in 2012. Rienhoff’s involvement in biotech became deeply personal in 2003, when his daughter was born with a mysterious defect that prevented her body from building muscle. His pleas for genetic analysis rejected, Rienhoff set out to do it himself, turning his attic into a home laboratory where he spent his nights combing through her DNA at the molecular level, hunting for clues that might suggest a treatment. That decade-long odyssey—ultimately successful—inspired him to start, a forum and advocate for other parents of children with undiagnosed diseases.

top ^

Jeremiah Robison

VP of Software, Jawbone

Jeremiah Robison is responsible for software engineering, algorithms, and data science at Jawbone, a San Francisco company specializing in wearable technology and audio devices. His expertise is showcased in the popular Jawbone UP activity tracker, which has been praised for its elegant user experience. Earlier this year, Jawbone launched an open platform that will let the UP integrate with other health and fitness services. Prior to joining Jawbone in 2010, Robison was chief technology officer at Slide, where he spearheaded technology strategy and development. He has also worked for Openwave, where he designed and built the first HTML browser for mobile phones, and Apple, where he contributed to the handwriting-recognition software on the first Newton organizer. Robison is a computer science graduate of Stanford University, where he played on the national championship water polo team.

top ^

David Sink

Director of Client Solutions and Delivery, Watson Solutions, IBM


top ^

Halle Tecco

Founder & CEO, Rock Health

Halle Tecco cofounded Rock Health in 2010 as the first startup incubator devoted exclusively to digital health companies. She hatched the idea while pursuing her MBA at Harvard Business School, when she realized there was a disconnect between the worlds of health care and information technology. Rock Health aims to bridge that gap. It welcomes tech entrepreneurs with no health-sector experience and provides not just seed funding but industry expertise and access to a network of partners like Genentech, UnitedHealth, Quest Diagnostics, Kaiser, Harvard Medical School, and the Mayo Clinic. The company has graduated several classes of startups, focusing on areas from diagnostic tools and devices to analytics and administrative solutions. Tecco has been honored as one of the nation’s top young innovators in Forbes’ “30 Under 30” list and was hailed by CNN in “12 Entrepreneurs Reinventing Healthcare.”

2013 Moderators

top ^

Robert Capps

Deputy Editor, WIRED

Rob Capps oversees wired’s feature packages and special editorial projects, as well as the conferences and events division. He received a prestigious Gerald Loeb Award for his article “Why Things Fail,” listed by Byliner as one of the best nonfiction stories of 2012. His 2009 feature essay “The Good Enough Revolution” was discussed in publications ranging from The Economist to The New Yorker and was heralded by The New York Times Magazine as one of the ideas of the year.

top ^

Brendan I. Koerner

Contributing Editor, WIRED

Brendan Koerner is a regular contributor to WIRED, where he wrote the popular “Mr. Know-It-All” column for many years. He is the author of Now the Hell Will Start, which he’s currently adapting for filmmaker Spike Lee. His latest book is The Skies Belong to Us: Love and Terror in the Golden Age of Hijacking. A former columnist for The New York Times and Slate, Koerner was named one ofColumbia Journalism Review’s “Ten Young Writers on the Rise.” 

top ^

Cliff Kuang

Senior Editor (Design), WIRED

Cliff Kuang leads wired’s coverage of design, using it as a lens on the culture at large. His cover story “Like Magic” explored how designers are moving beyond tangible objects to shape our interactions with the digital realm. Kuang was previously the design editor at Fast Company and founding editor of Fast Company’s spinoff site, Co.Design, where he won a National Magazine Award. Before that, he served as a reviews editor at I.D. magazine and an assistant editor at The Economist.

top ^

Jeffrey O’Brien

Science & Technology Journalist

Jeff O’Brien has been covering science and technology for more than 20 years. He was a senior editor at WIRED (1999–2006) and Fortune (2006–2010), and he continues to write for both publications and for Bloomberg Businessweek. O’Brien served as editorial director for IBM’s THINK exhibit, originally staged at Lincoln Center in 2011 and now at Epcot. He is also a cofounder of the content and design studio StoryTK and coauthor of the book Making the World Work Better.

top ^

Adam Rogers

Articles Editor, WIRED

Adam Rogers oversees editorial content in the front of the magazine, including the Alpha, Ultra, Q, and Gadget Lab sections. He won the 2011 AAAS Kavli Science Journalism Award for his article “The Angels’ Share,” about a mysterious fungus that lives on whiskey fumes. He was also a writer and host of the PBS TV show Wired Science. Before joining wired in 2004, Rogers was a reporter for Newsweek. His book, Proof: The Science of Booze, comes out in June 2014. 

top ^

Caitlin Roper

Senior Editor, WIRED

Caitlin Roper assigns and edits articles across a wide range of subjects, from hackathons to the healing powers of horsehoe-crab blood, the history of the movie trailer, and deadly terrain-park physics. She is especially interested in animation, crime, psychology, and people obsessed by their pursuits—the weirder, the better. Roper was previously managing editor of The Paris Review. She has also worked in film and contributed to The Moth, Pop-Up magazine, and The Los Angeles Times.

top ^

Bill Wasik

Senior Editor, WIRED

Bill Wasik edits features about technology, science, and culture. Since joining WIRED in 2010, he has written on topics ranging from the Internet of Things to the TEDx conference series to the London “flash riots” of 2011. He is the author of And Then There’s This: How Stories Live and Die in Viral Culture and coauthor of Rabid: A Cultural History of the World’s Most Diabolical Virus. Previously Wasik was a senior editor at Harper’s Magazine

top ^

Carl Zimmer

Contributor, WIRED; Columnist, The New York Times

Carl Zimmer writes the weekly science column “Matter” for The New York Times and is a frequent contributor to wired and National Geographic, as well as the NPR program Radiolab. He is the author of twelve books, including Parasite Rex and Evolution: Making Sense of Life. Zimmer, who teaches science writing at Yale, has won the AAAS Kavli Science Journalism Award three times. He is, to his knowledge, the only writer after whom a species of tapeworm has been named.